We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
West’s SmartDose® platform has been selected as a finalist in the 19th Annual Medical Design Excellence Awards (MDEA) competition. Considered the medtech industry’s premier design competition, MDEA recognizes significant achievements in medical product design and engineering and the many people behind the scenes—engineers, scientists, designers and clinicians—who are responsible for the cutting-edge products that are improving patient healthcare.
For the 2017 MDEA, a jury of healthcare practitioners, designers, engineers, manufacturers and human factors experts selected finalists in nine medical technology product categories. Products were judged based on design and engineering innovation; function and user-related innovation; patient benefits; business benefits; and overall benefit to the healthcare system. West’s SmartDose platform is a finalist in the for the “Drug-Delivery and Combination Products” category.
The SmartDose platform is a single-use, electronic wearable injector that adheres to the patient’s body, usually on the abdomen. Discreet, intuitive, and designed to minimize discomfort, the SmartDose platform currently incorporates a polymer-based drug container (made from Daikyo Crystal Zenith® cyclic olefin polymer) with a drug delivery device that can be pre-programmed to deliver high volumes of viscous or sensitive drug products over time, making it easier for patients to self-administer medication outside of the clinical setting.
While developing the SmartDose platform, it became clear that when patients deem a drug delivery system inconvenient, there can be a negative effect on the emotional attitude and motivation to sustain adherent behavior. As a result, the SmartDose platform was developed with extensive human factors testing to address potential obstacles to compliance:
This year’s winners will be announced at the 2017 MDEA Ceremony on June 13, 2017, in conjunction with MD&M East event at the Jacob K. Javits Convention Center in New York. To learn more about the Medical Design Excellence Awards and the list of finalists, visit MDEAwards.com.
<span style="color: #000000;">Container closure integrity is defined as the ability and quality of a container closure system to provide protection and maintain efficacy and sterility during the shelf life of a sterile drug product. The ability of rubber components to prevent microbial ingress of parenteral containers can be measured by seal integrity.</span>
It can take more than 12 years and a major financial investment to bring a drug product to market.<sup>1</sup> A drug product’s success relies on its efficacy, safety and manufacturing efficiencies along with the use of innovative strategies to meet evolving market needs and reinforcement of patient adherence. The importance of container closure and delivery systems as critical to success in the pharmaceutical industry is becoming more visible especially in respect to pharmaceutical and biotech organizations that desire to proactively minimize their risks.
In the next post of our corporate responsibility blog series, we are talking about diversity. At West, the word diversity applies to many things: work experience, culture, education, thoughts and opinions. We’re seeking diversity in all of these aspects because we know that a workforce rich in diversity will be met with success. Read more about our initiatives in this area below.<br />
When choosing an elastomeric formulation for a stopper or plunger used to package parenteral drug products, there are several misconceptions related to the importance the elastomer class plays on the chemical and physical properties of the elastomer. Often we hear customers make general statements such as “chlorobutyl elastomers are better” or “bromobutyls have an advantage in property X.” In actuality, each elastomeric formulation is unique and has different properties that are independent of the class of elastomer.
Mitigate risk of contamination, enable accurate dosing, while maintaining the stability and sterility of parenteral products
English
Chinese
